VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TBPH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TBPHTheravance Biopharma, Inc.
$16.98$875M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTBPHPrice History

TBPH logoTheravance Biopharma, Inc. (TBPH) Stock Price History

Historical prices from 2014 to 2026

$16.98-0.02  (-0.12%)close Jul 1
Returns
1M
+4.2%
3M
+5.5%
YTD
-6.4%
1Y
+50.1%
3Y
+18.2%
5Y
+3.9%
ATH$43.44Jun 2017-60.9%
ATL$6.10Sep 2021pre-split
Avg Vol (50D)470K/ day
52-Week Range$10.82 — $21.03
LowCurrent: $16.98High

Loading 10-year price history...

TBPH Historical Performance

1 YearTotal Return
+50.1%
Price: +50.1%
3 YearsTotal Return
+65.3%
CAGR: +18.2%
Price: +65.3%
5 YearsTotal Return
+21.0%
CAGR: +3.9%
Price: +21.0%
YTD
-6.4%

TBPH Annual Returns

Year-by-year price performance · 2014–2026

Best+101.6%2025
Worst-37.0%2021
Up years5/13
2014-35.0%
2015+11.5%
2016+96.3%
2017-14.2%
2018-8.8%
2019-1.1%
2020-28.0%
2021-37.0%
2022-8.6%
2023+2.5%
2024-18.8%
2025+101.6%
2026+0.6%
2014 annual price return
-35.0%
2015 annual price return
+11.5%
2016 annual price return
+96.3%
2017 annual price return
-14.2%
2018 annual price return
-8.8%
2019 annual price return
-1.1%
2020 annual price return
-28.0%
2021 annual price return
-37.0%
2022 annual price return
-8.6%
2023 annual price return
+2.5%
2024 annual price return
-18.8%
2025 annual price return
+101.6%
2026 annual price return
+0.6%
LessMore
Alpha vs S&P 500
1Y+41.0%
3Y-2.8%
5Y-11.1%

Price returns only.

Download Historical Data

3,050 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

TBPH Stock Price Trajectory (2014–2026)

As of July 7, 2026, Theravance Biopharma, Inc. (TBPH) trades at $16.98, representing a +50.1% return over the past year. The stock has delivered a +21.0% total return over five years (+3.9% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $43.44 on June 26, 2017. From this peak, TBPH has corrected -60.9%, currently trading 1% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers INVA (+15.4% 1Y), PRGO (-58.5% 1Y), and SUPN (+50.7% 1Y), TBPH has underperformed the peer group average. Compare TBPH vs INVA →

TBPH Historical Price Data · from 2014

Rows 1–50 of 3,050
Date Open High Low Close Volume Change %
2026-07-0117.0217.0716.9616.981.30M-0.12%
2026-06-3017.0517.1416.9417.001.63M-0.35%
2026-06-2916.9717.1616.9717.063.10M-3.23%
2026-06-2617.4017.7217.2917.630+1.38%
2026-06-2517.3017.5917.2317.39305K+0.69%
2026-06-2417.0717.6717.0717.27658K+1.77%
2026-06-2316.6417.1016.6416.97659K+2.48%
2026-06-2216.6616.9216.4116.561.08M-0.12%
2026-06-1816.7216.8016.5316.58792K-0.78%
2026-06-1716.6116.8116.5216.71365K+0.12%
2026-06-1616.4216.7116.2816.69336K+2.27%
2026-06-1516.6116.6116.2116.32102K-1.92%
2026-06-1216.4216.6716.4216.64230K+0.91%
2026-06-1116.4716.5816.3616.49252K+0.73%
2026-06-1016.4816.6216.3016.37326K-0.73%
2026-06-0916.4816.5716.3516.49313K+1.23%
2026-06-0816.3116.4716.2516.29220K0.00%
2026-06-0516.6116.6616.2816.29229K-0.49%
2026-06-0416.1216.4616.0516.37396K+2.83%
2026-06-0315.6516.1815.6515.92331K+2.18%
2026-06-0215.8315.8315.5215.58815K-2.26%
2026-06-0116.0016.1615.9015.94389K-0.75%
2026-05-2916.2116.2516.0316.06450K-0.93%
2026-05-2816.2616.4016.0516.21350K-0.31%
2026-05-2716.3616.4916.2016.26317K-0.91%
2026-05-2616.3316.4416.0816.41365K+0.24%
2026-05-2216.3116.3816.1816.37265K+0.18%
2026-05-2116.4516.6016.3016.34257K-1.27%
2026-05-2016.3616.5816.2816.55464K+1.85%
2026-05-1916.2216.3216.0116.25307K-0.06%
2026-05-1816.2116.4716.2016.26363K+0.25%
2026-05-1516.4916.5916.2116.22517K-1.76%
2026-05-1416.7916.7916.4316.51368K-0.93%
2026-05-1316.3616.7616.3616.66369K+1.12%
2026-05-1216.5316.6116.4116.48257K-0.24%
2026-05-1116.9616.9616.4216.52394K-2.88%
2026-05-0816.7817.0716.6117.01221K-0.06%
2026-05-0716.9417.0516.6217.02343K+0.47%
2026-05-0616.7117.0516.6816.94313K+1.26%
2026-05-0516.9817.1716.6516.73122K-1.06%
2026-05-0416.6816.9316.6016.91191K+0.71%
2026-05-0116.8116.8416.5716.79288K+0.30%
2026-04-3016.7716.8216.5316.74191K+0.42%
2026-04-2916.5816.7516.4516.67292K-0.54%
2026-04-2816.8616.9916.5416.76309K-0.30%
2026-04-2716.6416.9516.3816.81250K+2.13%
2026-04-2416.2616.5016.1416.46269K+0.92%
2026-04-2316.5416.5416.3016.31293K-1.57%
2026-04-2216.7216.7416.3216.57432K-0.30%
2026-04-2116.6716.9416.4616.62479K-0.60%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TBPH — Frequently Asked Questions

Quick answers to the most common questions about buying TBPH stock.

How has TBPH stock performed recently?

TBPH returned +50.1% over the past year, beating its 5-year annualized CAGR of +3.9%. The stock trades above its 200-day moving average, confirming the uptrend.

What is TBPH's all-time high price?

Theravance Biopharma, Inc. reached $43.44 on 2017-06-26. The 52-week high is $21.03. Current 1-year return of +50.1% places the stock closer to historical peaks.

Where can I download TBPH historical price data?

This page provides TBPH daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

437 data points · sampled from 3,050